公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; MEI-JYH CHEN ; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 18 | 15 | |
2020 | Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan | MEI-JYH CHEN ; YU-JEN FANG ; MING-SHIANG WU ; CHIEH-CHANG CHEN ; YEN-NIEN CHEN ; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Gastroenterology and Hepatology (Australia) | 9 | 7 | |
2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; MEI-JYH CHEN ; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 6 | |
2022 | Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis | MEI-JYH CHEN ; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG ; CHIEH-CHANG CHEN ; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Kun-Pei Lin ; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; JAW-TOWN LIN ; YI-CHIA LEE ; MING-SHIANG WU ; JYH-MING LIOU ; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium | Helicobacter | 7 | 6 | |
2018 | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection | Liou, Jyh-Ming; Chen, Po-Yueh; Luo, Jiing-Chyuan; Lee, Ji-Yuh; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang, Tsung-Hua; Chang, Chi-Yang; Bair, Ming-Jong; MEI-JYH CHEN ; Hsu, Yao-Chun; WEN-FENG HSU ; Chang, Chun-Chao; JAW-TOWN LIN ; CHIA-TUNG SHUN ; El-Omar, Emad M.; MING-SHIANG WU ; Liou, Jyh-Ming; YI-CHIA LEE ; Lin, Jaw-Town; Wu, Chun-Ying; Wu, Jeng-Yih; Lin, Chun-Hung; Fang, Yu-Ren; Luo, Jiing-Chyuan; TSU-YAO CHENG ; PING-HUEI TSENG ; HAN-MO CHIU ; Chang, Chun-Chao; Yu, Chien-Chun; Chiu, Min-Chin; YEN-NIEN CHEN ; Hu, Wen-Hao; Chou, Chu-Kuang; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun; Chang, Wen-Shiung; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gastroenterology | 61 | 50 | |
2019 | From germ theory to germ therapy | CHIEH-CHANG CHEN ; YEN-NIEN CHEN ; JYH-MING LIOU ; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Kaohsiung Journal of Medical Sciences | 5 | 5 | |
2017 | Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials | MEI-JYH CHEN ; MING-SHIANG WU ; CHIEN-CHUAN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; WEN-FENG HSU ; Luo J.-C.; Lin J.-T.; JYH-MING LIOU ; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 21 | 20 | |
2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 65 | 63 | |
2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 62 | 59 | |
2019 | Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication | Yeo Y.H.; Hsu C.-C.; Lee C.-C.; Ho H.J.; Lin J.-T.; MING-SHIANG WU ; JYH-MING LIOU ; Wu C.-Y.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Gastroenterology and Hepatology (Australia) | 24 | 22 | |
2018 | Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection | MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YEN-NIEN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lin J.-T.; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | American Journal of Gastroenterology | 30 | 25 | |
2016 | Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection | Chen P.-Y.; MING-SHIANG WU ; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Alimentary Pharmacology and Therapeutics | 60 | 52 | |
2022 | Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy | JYH-MING LIOU ; YI-CHIA LEE ; MING-SHIANG WU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Gut and Liver | 13 | 11 | |